The panel of ancillary IHC markers most frequently utilised to confirm the diagnosis of MM comprised S100, HMB45, tyrosinase, melan‐A (MART1), and SOX10 (Table 1). This evidence concerns the gene PMEL and Miyoshi myopathy.